financetom
Business
financetom
/
Business
/
Bandhan Bank Q2 profit down 5% at Rs 920 cr
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bandhan Bank Q2 profit down 5% at Rs 920 cr
Nov 2, 2020 6:16 AM

Bandhan Bank on Monday reported 5.3 percent decline in net profit at Rs 920 crore for September quarter of the current fiscal year. The bank clocked a net profit of Rs 971.80 crore in the same period of 2019-20.

Total income grew 22 percent to Rs 2,304.90 crore in July-September 2020-21 as against Rs 1,889.30 crore in the year-ago period, Bandhan Bank said in a regulatory filing. Net interest income of the Kolkata-headquartered lender jumped 25.8 percent to Rs 1,923.1 crore during the quarter while the non-interest income grew 6.1 percent to Rs 381.8 crore.

Bandhan Bank said it has reported the highest ever quarterly profit before tax at Rs 1,233 crore during the period under review. Net Interest Margin (annualised) in the quarter fell to 8 percent against 8.2 percent in year-ago period. During the quarter, the bank took accelerated additional provision on standard advances amounting to Rs 300 crore. With this provision and the additional standard assets provision that bank is carrying in micro banking portfolio, the total additional provision in books stands at Rs 2,096 crore, it said.

The bank’s gross non-performing assets fell to 1.2 percent (Rs 874 crore) of gross advances as of September 30, 2020 as against 1.8 percent (Rs 1,064.20 crore) by the year-ago same period. Net NPAs too improved to 0.4 percent (Rs 262.50 crore) from 0.6 percent (Rs 336.90 crore).

”As the moratorium ended on 31st August 2020 coupled with robust rural performance, we have seen an all-round improvement in collection, disbursement and deposits. On deposits front, we have witnessed the best ever quarter whereas on the disbursement front, we are close to pre-COVID-19 level.”

Collections have seen a steady improvement month-on-month and is expected to reach near normal in the next 90 days. We now look forward to accelerate the business in H2FY 21,” Managing Director and CEO Chandra Shekhar Ghosh said. Total Advances grew 19.4 percent to Rs 76,614.6 crore as on September 30, 2020. Total deposits increased 34.4 percent to Rs 66,127.7 crore.

Bandhan Bank stock was trading at Rs 305.50 on BSE, up 5.62 percent from the previous close.

First Published:Nov 2, 2020 3:16 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Magna Appoints Philip Fracassa CFO
Magna Appoints Philip Fracassa CFO
Sep 11, 2025
07:24 AM EDT, 09/11/2025 (MT Newswires) -- Magna International ( MGA ) said Thursday it has appointed Philip Fracassa as executive vice president and chief financial officer, effective immediately. Fracassa joins the company from Timken (TKR), where he was the finance chief, Magna added. He will succeed Patrick McCann, who will step down and remain with Magna in an advisory...
Merck Says Capvaxive Shows Immune Response in Children With High-Risk of Pneumococcal Disease in Phase 3 Trial
Merck Says Capvaxive Shows Immune Response in Children With High-Risk of Pneumococcal Disease in Phase 3 Trial
Sep 11, 2025
07:25 AM EDT, 09/11/2025 (MT Newswires) -- Merck ( MRK ) said Thursday that a phase 3 trial of its experimental vaccine, Capvaxive, for children and adolescents aged two to under 18 with chronic medical conditions that increase their risk of pneumococcal disease, showed strong immune responses to all 21 targeted serotypes. The drugmaker said its vaccine was non-inferior to...
Enovix Prices $300 Million Private Debt Offering; Shares Down Pre-Bell
Enovix Prices $300 Million Private Debt Offering; Shares Down Pre-Bell
Sep 11, 2025
07:27 AM EDT, 09/11/2025 (MT Newswires) -- Enovix ( ENVX ) said Thursday it priced a $300 million private offering of 4.75% convertible senior notes due Sept. 15, 2030, for about $290.4 million in expected net proceeds. Initial purchasers have an option to buy up to an additional $60 million of the notes. The company expects the offering to close...
KalVista Pharmaceuticals Fiscal Q1 Loss Widens, Posts Net Product Revenue
KalVista Pharmaceuticals Fiscal Q1 Loss Widens, Posts Net Product Revenue
Sep 11, 2025
07:24 AM EDT, 09/11/2025 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) reported a fiscal Q1 net loss Thursday of $1.12 per diluted share, wider than the loss of a $0.87 loss a year earlier. An analyst polled by FactSet expected a loss of $0.95. Net product revenue for the fiscal quarter ended July 31 was $1.4 million. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved